Amoxicillin And Clavulanate Potassium Powder, For Suspension
Product Images NDC 73043-008

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Amoxicillin And Clavulanate Potassium (NDC 73043-008). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Devatis Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula For Amoxicillin (Image 01)

Chemical structure of Amoxicillin and Clavulanate Potassium, depicting the molecular arrangement of atoms including a beta-lactam ring and associated functional groups, consistent with the antibiotic's chemical composition.*

FDA Label Image

Structural Formula For Clavulanic Acid (Image 02)

Chemical structure diagram of Amoxicillin and Clavulanate Potassium, showing the molecular framework including key functional groups such as the beta-lactam ring and side chains relevant to its antibiotic properties.*

FDA Label Image

Label (Image 03)

Label for Amoxicillin and Clavulanate Potassium for Oral Suspension, USP, 600 mg/42.9 mg per 5 mL, powder for suspension. The label includes mixing directions, storage instructions, ingredient strengths, a 200 mL reconstituted volume indication, and distribution by Devatis Inc. in San Clemente, CA. The product is made in Turkey.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.